BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 8266491)

  • 1. Effect of HLA matching on graft survival in live donor kidney transplantations.
    Velidedeoğlu E; Bilgin N; Haberal M
    Transplant Proc; 1993 Dec; 25(6):3144-5. PubMed ID: 8266491
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of HLA matching on the outcome of simultaneous pancreas-kidney transplantation.
    Berney T; Malaise J; Morel P; Toso C; Demuylder-Mischler S; Majno P; Bühler LH; Mentha G;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii48-53, ii62. PubMed ID: 15814550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney transplantation in children.
    Cuhadaroğlu S; Velidedeoğlu E; Haberal M
    Transplant Proc; 1993 Jun; 25(3):2174-5. PubMed ID: 8516858
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of HLA matching in cadaveric renal transplantation--influence of improved serologic HLA-DR typing.
    Leivestad T; Sødal G; Bratlie A; Albrechtsen D; Fauchald P; Pfeffer P; Vartdal F; Thorsby E
    Transplant Proc; 1993 Feb; 25(1 Pt 1):220-1. PubMed ID: 8438277
    [No Abstract]   [Full Text] [Related]  

  • 5. HLA-DR1, -DR5, and -DR8 antigen disparities are associated with acute steroid-resistant rejection and poor kidney graft survival.
    Salmela K; von Willebrand E; Kyllönen L; Koskimies S; Isoniemi H; Eklund B; Höckerstedt K; Ahonen J
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1272-3. PubMed ID: 1899160
    [No Abstract]   [Full Text] [Related]  

  • 6. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
    Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
    Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability of HLA typing on peripheral blood lymphocytes in cadaveric organ donors and the impact of blank donor antigens on kidney graft survival.
    Offermann G; Bünte S; Angelides U; Geidner U; Kirschbaum B; Müller E; Wendt N
    Transplant Proc; 1992 Dec; 24(6):2488-9. PubMed ID: 1361261
    [No Abstract]   [Full Text] [Related]  

  • 8. Beneficial HLA matching: its phase of impact on graft survival.
    Gilks WR; Bradley BA; Gore SM
    Transplant Proc; 1987 Feb; 19(1 Pt 1):664-5. PubMed ID: 3274833
    [No Abstract]   [Full Text] [Related]  

  • 9. HLA matching and short/long-term outcome of cadaveric renal allografts: large single-centre data confirm the multicentre analyses.
    Petersen P; Schneeberger H; Schleibner S; Illner WD; Hofmann GO; Scholz S; Albert ED; Land W
    Transplant Proc; 1995 Feb; 27(1):651-2. PubMed ID: 7879131
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal transplant graft survival results and HLA-A,B, DR mismatching.
    Cicciarelli J; Iwaki Y; McCalmon R; Thompson J
    Transplant Proc; 1995 Feb; 27(1):660-3. PubMed ID: 7879135
    [No Abstract]   [Full Text] [Related]  

  • 11. HLA-DR matching and anti-donor-specific antibodies in kidney transplant recipients.
    Valeri M; Piazza A; Torlone N; Poggi E; Monaco PI; Provenzani L; Adorno D; Casciani CU
    Transplant Proc; 1992 Dec; 24(6):2514-6. PubMed ID: 1465850
    [No Abstract]   [Full Text] [Related]  

  • 12. Organ shortage and a long waiting list allow local kidney allocation to insure both short ischemia time and good HLA-A, B, DR matching.
    Mosca F; Bertoni E; Tosi P; Bandini S; Rosati A; Pradella F; Mattiuz P; Taddei G; Nicita G; Rindi P
    Transplant Proc; 1995 Oct; 27(5):2695-6. PubMed ID: 7482878
    [No Abstract]   [Full Text] [Related]  

  • 13. Beneficial effect of DR matching on cadaveric renal graft survival in Scandiatransplant.
    Leivestad T; Berger L; Thorsby E
    Transplant Proc; 1992 Dec; 24(6):2447-8. PubMed ID: 1465824
    [No Abstract]   [Full Text] [Related]  

  • 14. Critical importance of HLA antigen matching in cadaveric kidney transplantation with high overall survival rates. The Manchester UK Kidney Transplant Team.
    Dyer PA; Martin S; Johnson RW
    Transplant Proc; 1992 Dec; 24(6):2454. PubMed ID: 1465827
    [No Abstract]   [Full Text] [Related]  

  • 15. Quality of serological donor HLA typing: analysis of graft survival by HLA in renal transplantation recipients treated with cyclosporine.
    Thorogood J; Schreuder GM; Persijn GG; van Rood JJ
    Transplant Proc; 1992 Dec; 24(6):2485-7. PubMed ID: 1465839
    [No Abstract]   [Full Text] [Related]  

  • 16. How valid are risk factors for chronic transplant failure in renal transplant patients found in the literature with regard to our patients: results of a multivariate analysis.
    Kapsner T; Schneeberger H; Land W
    Transplant Proc; 1995 Feb; 27(1):878-80. PubMed ID: 7879217
    [No Abstract]   [Full Text] [Related]  

  • 17. Donor-specific transfusion in living related and unrelated donor kidney transplantation: minimal sensitization and excellent graft outcome.
    Kong JM; Jeong JH; Kang JK; Seong IG; Kim BC
    Transplant Proc; 1995 Feb; 27(1):1036-7. PubMed ID: 7878792
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of HLA-DR matching assessed by genomic analysis in long-term kidney allograft survivals.
    Dahmane D; Bierling P; Busson M; Bracq C; Seror T; Buisson C; Fruchaud G; Bourgeon B; Baron C; Weil B
    Transplant Proc; 1995 Apr; 27(2):1737. PubMed ID: 7725479
    [No Abstract]   [Full Text] [Related]  

  • 19. Allocation of cadaver kidneys according to HLA-DR matching alone would result in optimal graft outcome in most recipients.
    Vereerstraeten P; Abramowicz D; Andrien M; Dupont E; De Pauw L; Kinnaert P
    Transplant Proc; 1999; 31(1-2):739-41. PubMed ID: 10083315
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of HLA matching and T- and B-cell crossmatch on acute rejection and graft survival following liver transplantation.
    Chen M; Wade J; Levy GA; Greig PD
    Transplant Proc; 1994 Oct; 26(5):2695-6. PubMed ID: 7940844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.